Total Payments
$33,048
2023 Payments
$4,594
Companies
1
Transactions
83
Payment Breakdown by Category
Consulting$30,764 (93.1%)
Travel$1,534 (4.6%)
Other$750.00 (2.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $30,764 | 77 | 93.1% |
| Travel and Lodging | $1,534 | 5 | 4.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $750.00 | 1 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $33,048 | 83 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $4,594 | 8 | NOVARTIS PHARMACEUTICALS CORPORATION ($4,594) |
| 2022 | $7,929 | 18 | Novartis Pharmaceuticals Corporation ($7,929) |
| 2021 | $5,885 | 19 | NOVARTIS PHARMACEUTICALS CORPORATION ($5,885) |
| 2020 | $5,220 | 16 | Novartis Pharmaceuticals Corporation ($5,220) |
| 2019 | $4,120 | 9 | Novartis Pharmaceuticals Corporation ($4,120) |
| 2018 | $4,660 | 11 | Novartis Pharmaceuticals Corporation ($4,660) |
| 2017 | $640.00 | 2 | Novartis Pharmaceuticals Corporation ($640.00) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 2 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/12/2022 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $228.15 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $40.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $40.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $40.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $40.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | MAYZENT (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | MAYZENT (Drug) | Consulting Fee | Cash or cash equivalent | $40.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $40.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $40.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $40.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $40.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2020 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2020 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $40.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2020 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2020 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $40.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/22/2020 | Novartis Pharmaceuticals Corporation | GILENYA (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: NEUROSCIENCE | ||||||
About Dr. Eric Aspinwall, MD
Dr. Eric Aspinwall, MD is a Family Medicine healthcare provider based in Kansas City, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1073557237.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Aspinwall, MD has received a total of $33,048 in payments from pharmaceutical and medical device companies, with $4,594 received in 2023. These payments were reported across 83 transactions from 1 company. The most common payment nature is "Consulting Fee" ($30,764).
Ad
Practice Information
- Specialty Family Medicine
- Location Kansas City, KS
- Active Since 06/16/2006
- Last Updated 11/07/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1073557237
Products in Payments
- GILENYA (Drug) $29,529
- MAYZENT (Drug) $3,519
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Kansas City
Dr. Meredith Levine, M.d, M.D
Family Medicine — Payments: $38,004
Family Medicine $38,004
Dr. Maurice Blodgett, D.o, D.O
Family Medicine — Payments: $30,998
Family Medicine $30,998
Dr. Blair Thedinger
Family Medicine — Payments: $19,784
Family Medicine $19,784
Dr. Julie Alvarez, Md, MD
Family Medicine — Payments: $19,673
Family Medicine $19,673
Teresa Marshall, M.d, M.D
Family Medicine — Payments: $19,051
Family Medicine $19,051
Michael Simanovsky, M.d, M.D
Family Medicine — Payments: $16,366
Family Medicine $16,366